EVANOVA CAPSULE

Indications

• Bladder irrigation during urological surgery
• Irrigation for transurethral resection of the prostate gland
• Irrigation for bladder tumors

Dosage

Children: Refer to the BNF for Children for pediatric dosing guidelines.

Adults: Refer to the product literature for specific dosing information.

Mechanism of action

Glycine binds to strychnine-sensitive and strychnine-insensitive glycine receptors in the central nervous system. The strychnine-sensitive receptor is a chloride channel that enhances inhibitory neurotransmission. This action may contribute to glycine's potential antispastic effects. Additionally, glycine potentiates NMDA receptor-mediated neurotransmission, which may have implications in managing certain neurological conditions, such as neuroleptic-resistant negative symptoms in schizophrenia.

Pharmacodynamics

Glycine plays a crucial role in various biological functions, including energy metabolism and immune response. It is involved in hormone synthesis and helps in modulating neurotransmitter release, particularly in inhibitory pathways. Glycine's ability to enhance chloride conductance in neurons contributes to its antispastic properties and its potential to mitigate oxidative stress in immune responses.

Pharmacokinetics

Glycine is absorbed readily in the gastrointestinal tract and is utilized by the body for protein synthesis and other metabolic functions. The distribution of glycine in the body is widespread, as it is present in various tissues. Glycine is metabolized in the liver and other tissues, with excretion primarily occurring via the kidneys. The pharmacokinetics of glycine can be influenced by factors such as age, renal function, and overall health status.

Adverse effects

• Fluid overload
• Electrolyte imbalance
• Nausea
• Vomiting
• Headache
• Hypotension

Precautions

• Monitor for signs of fluid overload during irrigation
• Use caution in patients with pre-existing electrolyte imbalances
• Careful consideration in patients with renal impairment

Pregnancy

Glycine is generally considered safe for use during pregnancy when used as an irrigation solution, but risks should be discussed with a healthcare provider.

Breast-feeding

Glycine is likely safe during breastfeeding, but limited data is available. Consultation with a healthcare professional is advisable.

Storage

Store in a cool, dry place. Protect from light. Do not freeze.

Formulations

• Glycine 1.5% irrigation solution 3 litre Easyflow bags
• Glycine 1.5% irrigation solution 1 litre Flowfusor bottles
• Glycine 1.5% irrigation solution 1 litre Easyflow bags
• Glycine 1.5% irrigation solution 2 litre Flowfusor bottles

Indications

• Pain relief
• Inflammation reduction
• Potential antimicrobial effects

Dosage

Children: Paediatric dosing should be carefully determined based on individual clinical circumstances and the specific preparation used; consult the relevant guidelines for accurate dosing recommendations.

Adults: Dosage recommendations for adults can vary widely based on specific formulations and intended use; consult relevant pharmacological sources or healthcare professionals for guidance.

Mechanism of action

The mechanism of action of abrak is not well-defined in contemporary pharmacological literature. However, it is generally thought to exert its effects through modulation of inflammatory pathways and inhibition of pain signaling pathways in the body. It may enhance the release of certain neurotransmitters or inhibit the activity of cyclooxygenase enzymes, leading to reduced pain and inflammation.

Pharmacodynamics

Abrak may exhibit analgesic, anti-inflammatory, and possibly antimicrobial properties. These effects are likely mediated through interactions with various receptor systems in the body, including those involved in pain perception and immune response modulation. The specific pharmacodynamic profile can vary considerably based on the formulation and dosage used.

Pharmacokinetics

The pharmacokinetics of abrak is largely uncharacterized in scientific literature. It is presumed that, like many herbal and traditional medicines, the absorption, distribution, metabolism, and excretion of its active components may be influenced by several factors, including the method of preparation, dosage, and individual patient characteristics. Further research is needed to establish clear pharmacokinetic parameters.

Pregnancy

There is insufficient data on the safety of abrak during pregnancy. It is advisable to avoid use unless absolutely necessary and prescribed by a healthcare professional.

Breast-feeding

Data on the excretion of abrak in human milk is limited. Caution is advised when administering to breastfeeding mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Digestive disorders
• Diarrhea
• Constipation
• Respiratory infections
• Inflammatory conditions
• Metabolic disorders

Dosage

Children: Refer to established pharmacological guidelines and clinical literature for specific dosing recommendations, which may vary based on the preparation used.

Adults: Refer to established pharmacological guidelines and clinical literature for specific dosing recommendations, which may vary based on the preparation used.

Mechanism of action

The active compounds in Aegle marmelos, such as flavonoids and alkaloids, exert their effects through multiple pathways, including the modulation of oxidative stress and inflammation. These compounds may inhibit various enzymes involved in the inflammatory pathways, enhance antioxidant defense systems, and promote gut health by modulating gut microbiota.

Pharmacodynamics

Aegle exhibits a range of pharmacological activities. It has demonstrated efficacy in reducing oxidative stress through the scavenging of free radicals. The anti-inflammatory properties are attributed to the inhibition of pro-inflammatory cytokines and enzymes, potentially benefiting conditions like arthritis and inflammatory bowel disease. Additionally, its antimicrobial effects contribute to its use in treating gastrointestinal infections and other infections.

Pharmacokinetics

The pharmacokinetics of Aegle marmelos are not well-characterized in clinical studies. However, the bioactive compounds are generally absorbed in the gastrointestinal tract, with distribution being influenced by their solubility and lipophilicity. Metabolism may occur in the liver, and excretion is likely through renal pathways. The onset of action can vary depending on the formulation and method of administration.

Pregnancy

There is limited information on the safety of Aegle during pregnancy. It is advisable to avoid use unless absolutely necessary and prescribed by a healthcare provider.

Breast-feeding

Due to insufficient data on the excretion of Aegle in breast milk, caution is advised when administering to breastfeeding mothers.

Storage

Store in a cool, dry place away from direct sunlight, and keep out of reach of children.

Indications

• Respiratory disorders
• Digestive issues
• Skin diseases
• Anemia
• General health and wellness

Dosage

Children: Paediatric dosing of bhasma is also variable and should be determined based on the child's age, weight, and specific health concerns. Consultation with a healthcare professional experienced in Ayurvedic medicine is advised.

Adults: Dosage for adults can vary widely based on the specific type of bhasma and the condition being treated. It is recommended to refer to traditional Ayurvedic guidelines or consult a qualified practitioner for specific dosing.

Mechanism of action

The exact mechanism of action of bhasma is not fully understood, but it is believed to involve the bioactive compounds released during the calcination process, which may exert antioxidant, anti-inflammatory, and immunomodulatory effects. These properties can enhance physiological functions and promote the healing processes in the body.

Pharmacodynamics

Bhasma exhibits various pharmacological effects, which may include modulation of immune responses, enhancement of metabolic functions, and promotion of detoxification processes. The bioavailability of minerals and metals in bhasma can lead to improved physiological activity, potentially affecting enzymatic activities and cellular signaling pathways.

Pharmacokinetics

Pharmacokinetic data specific to bhasma is limited due to its complex composition and traditional preparation methods. However, it is generally thought to be absorbed through the gastrointestinal tract when ingested, with its effects being dose-dependent. The elimination and metabolism of the components may vary based on individual physiology and the specific formulation of bhasma used.

Pregnancy

The safety of bhasma during pregnancy has not been well studied. It is advisable to consult a healthcare professional before use.

Breast-feeding

The excretion of bhasma in breast milk is not well documented. Caution is advised, and consultation with a healthcare professional is recommended.

Storage

Bhasma should be stored in a cool, dry place, away from direct sunlight and moisture, to maintain its potency and effectiveness.

Indications

• Dry cough
• Joint pain
• Inflammation
• Gastrointestinal disturbances

Dosage

Children: Refer to BNF for Children or homeopathic guidelines for specific dosing information, as it can vary widely based on formulation and intended use.

Adults: Refer to BNF or homeopathic guidelines for specific dosing information, as it can vary widely based on formulation and intended use.

Mechanism of action

The exact mechanism of action of bryonia is not well established in conventional pharmacology. However, it is believed to modulate inflammatory pathways and may exert effects on the central nervous system to alleviate pain. Homeopathic preparations are thought to work through the principles of dilution and succussion, leading to subtle changes in biological responses.

Pharmacodynamics

Bryonia is thought to have anti-inflammatory and analgesic properties, potentially reducing pain and inflammation associated with various conditions. Its effects may lead to improvements in symptoms such as cough suppression and relief from musculoskeletal discomfort.

Pharmacokinetics

Due to the highly diluted nature of homeopathic remedies like bryonia, traditional pharmacokinetic parameters such as absorption, distribution, metabolism, and excretion are not well defined. The extreme dilutions used in homeopathy may result in minimal or negligible pharmacological activity as understood in conventional medicine.

Pregnancy

Bryonia is not recommended during pregnancy due to its potential toxicity and lack of safety data.

Breast-feeding

Bryonia is not recommended during breastfeeding due to potential adverse effects on the infant.

Storage

Store in a cool, dry place, away from direct sunlight.

Indications

• Neurodegenerative diseases
• Inflammatory conditions
• Pain management
• Antioxidant therapy

Dosage

Children: Refer to specialized pediatric resources for dosing information, as no established pediatric dosing is available.

Adults: Refer to specific product guidelines and clinical studies for appropriate dosing, as no standardized dosage is universally established.

Mechanism of action

Celastrus species, particularly Celastrus angulatus, have shown to exert their effects through multiple pathways. Celastrol, a major compound, is known to inhibit the NF-kB signaling pathway, which plays a crucial role in inflammation and immune response. By modulating this pathway, celastrus may reduce inflammation and protect against cellular apoptosis. Additionally, celastrol has been reported to enhance the expression of heat shock proteins, which contribute to cellular protection under stress conditions.

Pharmacodynamics

The pharmacodynamic effects of celastrus are primarily linked to its anti-inflammatory and neuroprotective actions. It may reduce oxidative stress and improve cellular resilience, which is beneficial in neurodegenerative conditions. Furthermore, its potential to modulate various signaling pathways suggests a wide range of biological effects that could influence cell proliferation, apoptosis, and inflammatory responses.

Pharmacokinetics

The pharmacokinetics of celastrus compounds, particularly celastrol, includes oral absorption, distribution to tissues, and metabolism primarily in the liver. The bioavailability of celastrol can be affected by its formulation and the presence of other substances. Its elimination half-life and specific metabolic pathways are still under investigation, but it is known to undergo conjugation and excretion via bile and urine.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Vomiting
• Diarrhea
• Allergic reactions

Precautions

• Use with caution in patients with gastrointestinal disorders
• Monitor for potential allergic reactions

Pregnancy

There is insufficient reliable information on the safety of celastrus during pregnancy. It is advisable to avoid use unless clearly necessary.

Breast-feeding

Due to a lack of data on the excretion of celastrus in human milk, it is recommended to avoid use during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral capsules
• Powdered extract
• Liquid extract

Indications

• Stress relief
• Anxiety management
• Cognitive enhancement
• Improvement of physical performance
• Support for immune function

Dosage

Children: Refer to established herbal guidelines or consult with a healthcare provider for appropriate dosing.

Adults: Refer to established herbal guidelines or consult with a healthcare provider for appropriate dosing.

Mechanism of action

The primary active compounds in Cordifolia are known as withanolides, which exhibit a variety of pharmacological effects. These compounds modulate several signaling pathways, including the inhibition of the nuclear factor kappa B (NF-kB) and the activation of the AMP-activated protein kinase (AMPK). This modulation leads to anti-inflammatory, antioxidant, and neuroprotective effects. Additionally, withanolides may influence neurotransmitter levels, thereby aiding in mood regulation and cognitive enhancement.

Pharmacodynamics

Cordifolia demonstrates adaptogenic effects, helping the body resist stressors of various kinds. It has been shown to improve physical endurance, enhance memory and cognitive function, and exert a calming effect on the nervous system. The herb also exhibits immunomodulatory properties, promoting a healthy immune response while reducing inflammation.

Pharmacokinetics

The pharmacokinetics of Cordifolia are not extensively studied compared to conventional pharmaceuticals. However, it is generally understood that withanolides are absorbed in the gastrointestinal tract, undergo hepatic metabolism, and are excreted primarily through urine and feces. The bioavailability of these compounds can be affected by various factors, including formulation and dosage form.

Pregnancy

Insufficient data available; consult healthcare provider.

Breast-feeding

Insufficient data available; consult healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Digestive disorders
• Bloating and gas
• Loss of appetite
• Inflammation
• Antimicrobial activity

Dosage

Children: Refer to established guidelines or consult a healthcare provider for specific dosing recommendations in children, as the use of cumin may vary based on age and individual health needs.

Adults: Refer to established guidelines or consult a healthcare provider for specific dosing recommendations, as cumin can be used in various forms such as whole seeds, ground spice, or as an extract.

Mechanism of action

Cumin contains several active compounds, including cuminaldehyde, which is believed to exert antimicrobial and antioxidant effects. It may influence the activity of certain enzymes and modulate various biological pathways related to digestion and metabolism.

Pharmacodynamics

The pharmacodynamic effects of cumin are primarily attributed to its active constituents such as cuminaldehyde and other essential oils. These compounds may stimulate gastric secretions, enhance digestive enzyme activity, and possess anti-inflammatory and antioxidant properties, contributing to its therapeutic applications.

Pharmacokinetics

Cumin's pharmacokinetics have not been extensively studied. However, its active compounds are generally absorbed in the gastrointestinal tract, metabolized by the liver, and excreted via the urine. The bioavailability of its constituents may vary based on factors such as preparation and individual metabolism.

Adverse effects

• Allergic reactions
• Gastrointestinal upset
• Dermatitis

Interactions

• May interact with anticoagulants due to potential effects on blood clotting
• Can potentially alter the metabolism of certain drugs through cytochrome P450 enzymes

Precautions

• Use with caution in individuals with allergies to other plants in the Apiaceae family
• Monitor for gastrointestinal disturbances in sensitive individuals

Pregnancy

Limited data available, consult healthcare providers before use.

Breast-feeding

Generally considered safe, but consult healthcare providers.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Whole seeds
• Ground spice
• Essential oil

Indications

• Digestive disorders
• Anti-inflammatory conditions
• Antimicrobial therapy
• Antioxidant support

Dosage

Children: Refer to guidelines and clinical recommendations for appropriate doses in children, as specific dosage information is not available.

Adults: Refer to guidelines and clinical recommendations for appropriate doses, as specific dosage information is not available.

Mechanism of action

Cumin contains active compounds such as cuminaldehyde, which have been shown to exhibit antimicrobial and antioxidant activities. The mechanisms may involve the modulation of various signaling pathways and the inhibition of oxidative stress, contributing to its potential health benefits. Additionally, cumin may enhance digestive health by stimulating the secretion of digestive enzymes.

Pharmacodynamics

The pharmacodynamic properties of cumin are attributed to its active phytochemicals, which can influence various biological processes. Its antimicrobial properties help in preventing infections, while the antioxidant effects may protect cells from damage caused by free radicals. Cumin has also been reported to have anti-inflammatory properties, which can aid in reducing inflammation in various conditions.

Pharmacokinetics

The pharmacokinetics of cumin, including absorption, distribution, metabolism, and excretion, are not extensively characterized in clinical studies. However, it is known that the active compounds are absorbed in the gastrointestinal tract after ingestion. The metabolism primarily occurs in the liver, where these compounds may be converted into various metabolites. Excretion occurs mainly through urine, but specific pharmacokinetic parameters are not well-defined.

Pregnancy

Cyminum is generally considered safe during pregnancy when used in culinary amounts. However, high doses should be avoided due to potential effects on uterine contractions.

Breast-feeding

Cyminum is likely safe during breastfeeding in normal dietary amounts. High doses should be approached with caution.

Storage

Store in a cool, dry place away from direct sunlight. Keep in an airtight container to preserve freshness.

Formulations

• Whole seeds
• Ground powder

Indications

• Genital herpes
• Cold sores (herpes labialis)
• Shingles (herpes zoster)
• Chickenpox (varicella)

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations tailored to the child's weight and age.

Adults: Refer to the BNF for specific dosing information based on the condition being treated, patient age, and renal function.

Mechanism of action

Herpestis exerts its antiviral effects by interfering with the viral DNA synthesis. It is a nucleoside analogue that gets phosphorylated by viral thymidine kinase, converting it into its active triphosphate form. This active form then competes with natural deoxyguanosine triphosphate for incorporation into viral DNA, leading to premature chain termination during DNA replication. This mechanism effectively inhibits the replication of the virus.

Pharmacodynamics

The pharmacodynamics of herpestis involve its ability to selectively inhibit the replication of herpes viruses, which are DNA viruses. The drug shows a high affinity for the viral enzyme thymidine kinase, which is crucial for the phosphorylation and activation of the drug, thus enhancing its efficacy against infected cells. The reduction in viral load helps alleviate symptoms and aids in the resolution of the infection.

Pharmacokinetics

Herpestis is well absorbed after oral administration, with bioavailability ranging from 60-90%. It is widely distributed in body tissues and can penetrate the central nervous system. The drug is primarily excreted unchanged in the urine, with renal clearance being the principal route of elimination. The half-life of the drug is approximately 2-3 hours in individuals with normal renal function; however, it may be prolonged in patients with renal impairment, necessitating dose adjustment.

Pregnancy

Herpestis should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Caution is recommended when administering Herpestis during breastfeeding, as it is not known if it is excreted in human milk.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Indications

• Chronic pain management
• Anxiety disorders
• Sleep disorders
• Nausea and vomiting associated with chemotherapy
• Appetite stimulation in patients with cachexia

Dosage

Adults: Dosage varies widely based on form of administration and individual response. It is recommended to start with a low dose and gradually increase as needed, under guidance from a healthcare provider.

Mechanism of action

The primary active compounds in Indica cannabis are THC and CBD, which exert their effects by interacting with the endocannabinoid system. THC binds to cannabinoid receptors (CB1 and CB2) in the brain and peripheral tissues, leading to psychoactive effects and modulation of pain, mood, and appetite. CBD has a more complex mechanism, acting as a negative allosteric modulator of the CB1 receptor and influencing multiple neurotransmitter systems, which contributes to its anxiolytic and anti-inflammatory properties.

Pharmacodynamics

Indica strains may produce a range of effects including sedation, pain relief, and relaxation. The balance of THC and CBD can influence the overall experience, with higher THC levels typically associated with stronger psychoactive effects. The sedative properties of Indica strains are often attributed to their ability to enhance GABAergic transmission, which can lead to decreased neural excitability and promote sleep.

Pharmacokinetics

Cannabinoids are typically administered via inhalation, oral consumption, or topical application, with bioavailability varying by method. When smoked or vaporized, THC reaches peak plasma concentrations within minutes, while oral ingestion leads to a delayed onset of effects due to first-pass metabolism in the liver. The elimination half-life of THC is variable, ranging from 1 to 10 days, influenced by factors such as frequency of use and individual metabolism. CBD has a longer half-life and is extensively metabolized in the liver, affecting its pharmacokinetic profile.

Pregnancy

The safety of indica during pregnancy has not been established. Use should be approached with caution, and potential risks should be weighed against benefits.

Breast-feeding

The effects of indica on breastfeeding infants are not well documented. Caution is advised, and mothers should consult healthcare professionals before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Anxiety disorders
• Insomnia
• Stress-related disorders
• Neuroprotection
• Cognitive enhancement

Dosage

Children: Refer to established guidelines or consult a healthcare provider for appropriate dosing.

Adults: Refer to established guidelines or consult a healthcare provider for appropriate dosing.

Mechanism of action

The active compounds in Jatamansi, such as jatamansone and other sesquiterpenes, are thought to modulate neurotransmitter systems, particularly by enhancing GABAergic activity. This leads to increased inhibition of neuronal firing, contributing to its sedative effects. Jatamansi may also exhibit antioxidant properties, protecting neuronal cells from oxidative stress.

Pharmacodynamics

Jatamansi demonstrates a range of pharmacodynamic effects including sedative, anxiolytic, and relaxant properties. It is believed to influence the central nervous system by acting on GABA receptors, which helps in reducing anxiety and promoting sleep. Additionally, the herb may improve cognitive function and has been noted for its potential neuroprotective effects.

Pharmacokinetics

The pharmacokinetic profile of Jatamansi has not been extensively studied, but it is generally known that herbal extracts exhibit variable absorption, distribution, metabolism, and excretion based on their phytochemical composition. The bioactive compounds are likely metabolized in the liver, and their effects can vary based on the method of preparation and dosage form.

Contra-indications

• Hypersensitivity to jatamansi or its components
• Pregnancy
• Breastfeeding

Adverse effects

• Drowsiness
• Nausea
• Vomiting
• Diarrhea
• Allergic reactions

Interactions

• May enhance the effects of sedatives
• Caution with anticoagulants due to potential effects on bleeding

Precautions

• Use with caution in patients with liver or kidney disease
• Monitor for excessive sedation

Pregnancy

Use during pregnancy is not recommended due to insufficient safety data.

Breast-feeding

Safety during breastfeeding is not established, caution is advised.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Powder
• Capsules
• Extracts
• Tinctures

Indications

• Wound healing
• Anti-inflammatory conditions
• Pain relief
• Antimicrobial activity

Dosage

Children: Refer to established herbal guidelines or consult a healthcare provider for appropriate dosing.

Adults: Refer to established herbal guidelines or consult a healthcare provider for appropriate dosing.

Mechanism of action

The mechanism of action of laciniosa is not fully elucidated. However, it is believed to exhibit anti-inflammatory effects through the inhibition of pro-inflammatory cytokines and the modulation of immune responses. Components within the plant may also contribute to wound healing through promoting fibroblast proliferation and collagen synthesis.

Pharmacodynamics

The pharmacodynamics of laciniosa involve its active constituents interacting with various biological pathways. These interactions may lead to the reduction of inflammation and pain relief, as well as enhancing the healing process of tissues. Its effects may be mediated through the modulation of signaling pathways related to inflammation and tissue repair.

Pharmacokinetics

The pharmacokinetics of laciniosa have not been extensively studied. However, as with many herbal preparations, the bioavailability of its active ingredients may vary based on the method of extraction and administration. Factors such as absorption, distribution, metabolism, and excretion of the active compounds will largely influence its therapeutic efficacy.

Pregnancy

Not enough data available to determine safety during pregnancy. Caution is advised.

Breast-feeding

Not enough data available to determine safety during breastfeeding. Caution is advised.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Gastrointestinal disorders
• Diarrhea
• Dysentery
• Respiratory conditions
• Inflammatory conditions
• Antimicrobial therapy

Dosage

Children: Refer to herbal medicine guidelines or a qualified healthcare provider for appropriate dosing.

Adults: Refer to herbal medicine guidelines or a qualified healthcare provider for appropriate dosing.

Mechanism of action

The active constituents of marmelos, such as flavonoids and tannins, exhibit various pharmacological activities. These compounds are believed to exert anti-inflammatory effects by inhibiting pro-inflammatory mediators and enhancing antioxidant defense mechanisms. Additionally, marmelos may promote digestive health by stimulating gastric secretions and exhibiting antimicrobial properties against gastrointestinal pathogens.

Pharmacodynamics

Marmelos has been shown to modulate various biochemical pathways, including the inhibition of cyclooxygenase enzymes, leading to reduced prostaglandin synthesis and inflammation. Its antioxidant properties help combat oxidative stress, which is implicated in chronic diseases. Furthermore, the antimicrobial activity of marmelos may aid in protecting against infections, particularly in the gastrointestinal tract.

Pharmacokinetics

The pharmacokinetics of marmelos have not been extensively studied in clinical settings. However, it is known that the bioactive compounds are absorbed in the gastrointestinal tract, where they exert their effects. The metabolism and excretion pathways are not well defined, necessitating further research to clarify these aspects.

Pregnancy

There is insufficient reliable information regarding the safety of marmelos during pregnancy. It is advisable to consult a healthcare professional before use.

Breast-feeding

Due to limited data on the excretion of marmelos in breast milk, caution is recommended. It is best to consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Type 2 diabetes mellitus
• Hyperglycemia
• Weight management
• Sugar cravings

Dosage

Children: Refer to established clinical guidelines for specific dosing recommendations, as doses may vary based on the form and concentration of the extract used.

Adults: Refer to established clinical guidelines for specific dosing recommendations, as doses may vary based on the form and concentration of the extract used.

Mechanism of action

The primary mechanism of action of monniera involves the inhibition of intestinal absorption of glucose, as well as a reduction in the sweet taste sensation by blocking sweetness receptors on the tongue. This can potentially lead to decreased sugar cravings and lower blood sugar levels.

Pharmacodynamics

Monniera exhibits hypoglycemic effects, which may be mediated through its ability to stimulate insulin secretion from the pancreas and enhance glucose uptake in peripheral tissues. The gymnemic acids also have a role in modulating carbohydrate metabolism, thereby contributing to its overall blood sugar-lowering effects.

Pharmacokinetics

The pharmacokinetics of monniera are not extensively characterized. However, gymnemic acids are thought to be absorbed in the gastrointestinal tract, with their effects lasting several hours. The exact metabolic pathways and elimination routes remain to be fully elucidated.

Pregnancy

There is insufficient evidence regarding the safety of monniera during pregnancy. It is advisable to consult a healthcare professional before use.

Breast-feeding

Safety during breastfeeding has not been established. Consult a healthcare provider before use.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Indications

• Anxiety disorders
• Insomnia
• Stress-related conditions
• Neuroprotection
• Inflammatory conditions

Dosage

Children: Refer to a healthcare professional or appropriate pediatric dosing references for children, as specific dosing information is not established.

Adults: Dosage for adults varies based on the formulation and intended use, typically ranging from 500 mg to 1500 mg daily, depending on the extract and concentration. Refer to specific product guidelines for dosing.

Mechanism of action

Nardostachys exhibits its effects primarily through modulation of the central nervous system. The active compounds, such as valeranones and jatamansone, may influence neurotransmitter systems, particularly GABAergic pathways, leading to anxiolytic and sedative effects. Additionally, its anti-inflammatory properties are attributed to the inhibition of pro-inflammatory cytokines and the modulation of oxidative stress pathways.

Pharmacodynamics

The pharmacodynamic effects of nardostachys include anxiolytic, sedative, and neuroprotective actions. It may enhance GABA activity, leading to a calming effect on the nervous system. The anti-inflammatory properties help in reducing inflammation and may be beneficial in conditions characterized by oxidative stress. Its tonic properties support overall well-being and may improve cognitive function and mood.

Pharmacokinetics

The pharmacokinetics of nardostachys are not extensively studied, but it is believed that the active constituents are absorbed through the gastrointestinal tract after oral administration. The metabolism and excretion pathways remain unclear due to limited clinical data. However, like many herbal remedies, the bioavailability may be influenced by the formulation and the presence of other compounds.

Pregnancy

There is insufficient data on the safety of nardostachys during pregnancy. Use with caution and consult a healthcare professional.

Breast-feeding

Limited information is available regarding the excretion of nardostachys in breast milk. It is advisable to consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Cognitive enhancement
• Memory improvement
• Anxiety reduction
• Neuroprotection
• Stress relief

Dosage

Children: Refer to specialized pediatric guidelines; dosing should be conducted under professional supervision.

Adults: Refer to established guidelines for dosing; typically, dosages range from 300 to 600 mg of standardized extract per day.

Mechanism of action

The active compounds in Paniculatus, primarily bacosides, are believed to enhance synaptic transmission and promote neuroplasticity. They facilitate the repair of damaged neurons and improve signaling pathways associated with cognitive function. This herb also demonstrates antioxidant properties, reducing oxidative stress in neural tissues, which may contribute to its neuroprotective effects.

Pharmacodynamics

Paniculatus exhibits several pharmacodynamic effects, including enhancement of cognitive function, modulation of neurotransmitter levels (such as serotonin and acetylcholine), and reduction of anxiety. Its adaptogenic properties help the body resist stressors, while its anti-inflammatory effects may contribute to overall brain health and function.

Pharmacokinetics

The pharmacokinetics of Paniculatus are characterized by its oral bioavailability, although specific absorption rates and half-lives are not well-documented. After ingestion, the active components are absorbed and metabolized, with peak plasma concentrations generally occurring within a few hours. The elimination pathways may involve hepatic metabolism and renal excretion, though comprehensive studies on these parameters are limited.

Pregnancy

Limited data is available on the safety of paniculatus during pregnancy. It is advised to use caution and consult a healthcare provider before use.

Breast-feeding

There is insufficient information on the excretion of paniculatus in human milk. Caution is advised, and a healthcare provider should be consulted.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Menstrual disorders
• Dysmenorrhea
• Uterine health
• Antioxidant support
• Anti-inflammatory conditions

Dosage

Children: Refer to established herbal guidelines or consult a healthcare provider for specific dosing information, as doses can vary based on preparation and individual patient factors.

Adults: Refer to established herbal guidelines or consult a healthcare provider for specific dosing information, as doses can vary based on preparation and individual patient factors.

Mechanism of action

The exact mechanism of action of Saraca is not fully elucidated, but it is hypothesized that its efficacy in treating gynecological issues is linked to its ability to modulate hormonal levels and improve uterine health. The presence of flavonoids and other phytochemicals may contribute to its antioxidant effects, reducing oxidative stress and promoting overall reproductive health.

Pharmacodynamics

Saraca exhibits various pharmacological effects, including anti-inflammatory, analgesic, and antimicrobial properties. Its compounds may influence hormonal activities, particularly those related to the menstrual cycle, and contribute to the regulation of menstrual flow and relief from dysmenorrhea. The antioxidant activity of Saraca helps protect cells from damage caused by free radicals, potentially enhancing reproductive health.

Pharmacokinetics

The pharmacokinetics of Saraca are not well-defined in scientific literature. However, general principles suggest that the active compounds may be absorbed in the gastrointestinal tract, metabolized in the liver, and excreted through urine and feces. The onset and duration of action may vary based on the preparation and dosage form used.

Pregnancy

Insufficient data available on the safety of Saraca during pregnancy. Caution is advised.

Breast-feeding

Limited information is available regarding the excretion of Saraca in human milk. Its use during breastfeeding should be approached with caution.

Storage

Store in a cool, dry place away from light and moisture. Ensure the container is tightly closed.

Indications

• Management of menopausal symptoms
• Support for bone health
• Potential reduction of breast cancer risk
• Cardiovascular health support

Dosage

Children: Refer to specific product guidelines for dosing, as it varies based on the formulation and intended use.

Adults: Refer to specific product guidelines for dosing, as it varies based on the formulation and intended use.

Mechanism of action

Isoflavones in soy, particularly genistein and daidzein, exert their effects primarily through binding to estrogen receptors (ERs), particularly ER-beta. This binding can mimic the effects of estrogen in the body, potentially influencing various physiological processes, such as bone health and cardiovascular function. Additionally, soy isoflavones have been shown to modulate enzyme activity, reduce oxidative stress, and exhibit anti-inflammatory effects through various signaling pathways.

Pharmacodynamics

Soy isoflavones have been studied for their potential role in reducing menopausal symptoms, improving bone density, and lowering the risk of certain cancers, particularly hormone-dependent cancers such as breast and prostate cancer. They may also contribute to cardiovascular health by improving lipid profiles and reducing blood pressure.

Pharmacokinetics

After ingestion, soy isoflavones are absorbed in the intestine, undergo metabolism in the liver, and are excreted primarily through urine. The bioavailability of isoflavones can vary based on individual differences, dietary habits, and the specific form of soy consumed. Peak plasma concentrations of isoflavones typically occur 1 to 3 hours after consumption, with a half-life of several hours.

Adverse effects

• Allergic reactions
• Gastrointestinal disturbances such as nausea, vomiting, and diarrhea
• Potential hormonal effects due to phytoestrogens

Precautions

• Use with caution in individuals with soy allergies
• May interact with anticoagulant medications due to potential vitamin K content
• Monitor for effects in patients with thyroid disorders

Pregnancy

Soy products are generally considered safe during pregnancy when consumed in typical dietary amounts. However, excessive intake of soy supplements should be avoided.

Breast-feeding

Soy is considered safe during breastfeeding when consumed in normal dietary amounts.

Storage

Store in a cool, dry place, away from light and moisture. Keep out of reach of children.

Formulations

• Soybeans (whole)
• Soy milk
• Soy protein isolate
• Soy flour
• Soy oil
• Soy lecithin

Indications

• Diabetes mellitus
• Chronic infections
• Inflammatory conditions
• Immunomodulation
• Antioxidant support

Dosage

Children: Refer to specific traditional or herbal medicine guidelines, as there is no standardized dosage established in clinical settings.

Adults: Refer to specific traditional or herbal medicine guidelines, as there is no standardized dosage established in clinical settings.

Mechanism of action

The active compounds in Tinospora, such as tinosporide and other alkaloids, interact with various molecular pathways. They are believed to modulate immune responses by affecting the activity of immune cells, enhancing phagocytosis and promoting the production of cytokines. Additionally, the compounds may exhibit antioxidant effects by scavenging free radicals, thereby reducing oxidative stress.

Pharmacodynamics

Tinospora exerts various pharmacodynamic effects including immunomodulation, anti-inflammatory actions, and potential blood glucose-lowering effects. Its immunomodulatory effects may help enhance the body's defense against infections and diseases. The anti-inflammatory properties can contribute to the alleviation of symptoms in conditions such as arthritis and other inflammatory disorders.

Pharmacokinetics

The pharmacokinetics of Tinospora, including absorption, distribution, metabolism, and excretion, are not well-characterized in the literature. However, it is known that the active components are absorbed in the gastrointestinal tract after oral administration. The metabolites may be processed by the liver, and the elimination half-life can vary. Further studies are needed to fully elucidate the pharmacokinetic profile of Tinospora extracts.

Adverse effects

• Gastrointestinal upset
• Hypoglycemia
• Allergic reactions

Interactions

• May enhance the effects of antidiabetic medications, increasing the risk of hypoglycemia
• Potential interaction with immunosuppressants due to its immune-modulating effects

Precautions

• Use with caution in patients with diabetes due to potential hypoglycemic effects
• Monitor for allergic reactions in sensitive individuals

Pregnancy

Limited clinical data is available. Caution is advised due to insufficient evidence of safety.

Breast-feeding

Insufficient data available. Caution is advised as it may affect milk production or composition.

Storage

Store in a cool, dry place away from direct sunlight and moisture.

Formulations

• Oral extract
• Powdered form
• Capsules

Indications

• Severe infections caused by Gram-positive bacteria
• Methicillin-resistant Staphylococcus aureus (MRSA) infections
• Endocarditis
• Osteomyelitis
• Skin and soft tissue infections
• Pneumonia caused by MRSA
• Clostridium difficile infection (oral administration)

Dosage

Children: Refer to

Adults: Refer to the BNF for specific dosing guidelines based on the type and severity of infection.

Mechanism of action

Vancomycin works by inhibiting bacterial cell wall synthesis. It binds to the D-alanyl-D-alanine terminus of the cell wall precursor units, preventing their incorporation into the growing cell wall. This action disrupts the integrity of the bacterial cell wall, leading to cell lysis and death. Vancomycin is particularly effective against dividing bacteria that are actively synthesizing their cell walls.

Pharmacodynamics

The pharmacodynamics of vancomycin involve its time-dependent killing properties, meaning that the efficacy of the drug is related to the duration of time that serum concentrations exceed the minimum inhibitory concentration (MIC) for the target organism. The drug exhibits bactericidal activity against susceptible organisms, particularly against staphylococci and enterococci. Resistance can develop, particularly with enterococci, if vancomycin is used inappropriately.

Pharmacokinetics

Vancomycin is poorly absorbed from the gastrointestinal tract, which is why oral formulations are used primarily for localized infections like C. difficile. When administered intravenously, it distributes widely into body tissues and fluids. The volume of distribution is approximately 0.4 to 1 L/kg. Vancomycin is primarily eliminated by the kidneys, with a half-life ranging from 4 to 6 hours in individuals with normal renal function. Dosage adjustments may be necessary in patients with renal impairment.

Pregnancy

Data on the use of Vang in pregnancy is limited. It is advisable to use caution and consult healthcare professionals before use.

Breast-feeding

Information on the excretion of Vang in breast milk is not well established. Caution is advised when administering to breastfeeding mothers.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Zinc deficiency
• Copper deficiency
• Immune system support
• Wound healing
• Skin health support

Dosage

Children: Refer to specific guidelines for paediatric dosing, as it is essential to consider age, weight, and clinical condition.

Adults: Refer to specific guidelines for dosage, as it may vary based on the condition being treated and individual patient factors.

Mechanism of action

Zinc acts as a cofactor for numerous enzymes and plays a vital role in cellular processes such as DNA synthesis, protein synthesis, and cell division. Copper is involved in the formation of hemoglobin and collagen, and it also helps in the absorption of iron. Together, they contribute to various biochemical pathways that support immune function and overall health.

Pharmacodynamics

The pharmacodynamics of Yashad is characterized by its role in enhancing immune function, promoting skin integrity, and facilitating wound healing. Zinc is known to modulate the immune response by supporting the activity of T-lymphocytes and influencing cytokine production. Copper contributes to antioxidant defense and is essential for maintaining normal physiological functions.

Pharmacokinetics

Zinc and copper are absorbed in the gastrointestinal tract, with factors such as dietary intake and the presence of other minerals influencing absorption rates. Once absorbed, zinc is distributed throughout the body, primarily in skeletal muscle and bone, while copper is distributed in liver, brain, and kidney tissues. Both minerals are excreted primarily through urine, with zinc also lost in feces.

Pregnancy

The safety of Yashad during pregnancy has not been established. It is recommended to be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Yashad is excreted in breast milk, and caution should be exercised when administered to a nursing mother.

Storage

Store in a cool, dry place, away from direct light. Keep out of reach of children.

Mechanism of action

In the CNS, there exist strychnine-sensitive glycine binding sites as well as strychnine-insensitive glycine binding sites. The strychnine-insensitive glycine-binding site is located on the NMDA receptor complex. The strychnine-sensitive glycine receptor complex is comprised of a chloride channel and is a member of the ligand-gated ion channel superfamily. The putative antispastic activity of supplemental glycine could be mediated by glycine's binding to strychnine-sensitive binding sites in the spinal cord. This would result in increased chloride conductance and consequent enhancement of inhibitory neurotransmission. The ability of glycine to potentiate NMDA receptor-mediated neurotransmission raised the possibility of its use in the management of neuroleptic-resistant negative symptoms in schizophrenia. Animal studies indicate that supplemental glycine protects against endotoxin-induced lethality, hypoxia-reperfusion injury after liver transplantation, and D-galactosamine-mediated liver injury. Neutrophils are thought to participate in these pathologic processes via invasion of tissue and releasing such reactive oxygen species as superoxide. In vitro studies have shown that neutrophils contain a glycine-gated chloride channel that can attenuate increases in intracellular calcium and diminsh neutrophil oxidant production. This research is ealy-stage, but suggests that supplementary glycine may turn out to be useful in processes where neutrophil infiltration contributes to toxicity, such as ARDS. HYPERPOLARIZATION OF MOTONEURONS PRODUCED BY IONTOPHORETIC APPLICATION OF GLYCINE IS RELATIVELY TRANSIENT BUT APPROACHES THE EQUILIBRIUM POTENTIAL FOR THE INDIRECTLY ACTIVATED INHIBITORY POSTSYNAPTIC POTENTIAL...TESTS WITH GABA... INDICATE SIMILAR ELECTROPHYSIOLOGICAL EFFECTS & SIMILAR INCR IN CL- CONDUCTANCE. MAJOR EVIDENCE THAT FAVORS GLYCINE AS MEDIATOR OF INTRASPINAL POSTSYNAPTIC INHIBITION IS THE SELECTIVE ANTAGONISM OF ITS EFFECTS BY STRYCHNINE. ... GLYCINE ALSO APPEARS TO BE MOST LIKELY TRANSMITTER FOR INHIBITORY INTERNEURONS IN RETICULAR FORMATION BUT NOT IN CUNEATE NUCLEUS.

Pharmacodynamics

Helps trigger the release of oxygen to the energy requiring cell-making process; Important in the manufacturing of hormones responsible for a strong immune system.